Middle East Nuclear Imaging Market

Middle East Nuclear Imaging Market by Product (Equipment and Radioisotope) and Application (PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) Applications) -Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1483
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 154
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Middle East nuclear imaging market size is estimated to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising diagnostic applications in several diseases such as cancer and cardiovascular diseases, technological advancements, government support, and shift from standalone to hybrid modalities.


Middle East Nuclear Imaging Market summary

Nuclear imaging refers to an incipient imaging technology that uses a small quantity of radioactive substance connected to compounds utilizes by the body's compounds or cells that attach to tumor cells. Utilizing significant detection framework, the radioactive substances can be traced in the body to see where and when they accumulate and this method has the ability of improving medical diagnosis, clinical research, disease prevention, and treatment. PET creates computerized images of chemical alteration like sugar metabolism, which occurs in the tissue. Generally, the patient is given an injection of a combination of radioactively labeled sugar and sugar, radioactive sugar concentrates on the tumor in the body if it is present and can be traced with the help of a scanner. However, in SPECT a small dose of radioactive material is injected in the vein of the patient and can be traced by the use of a scanner to check the blood flow to tissue and chemical reactions in the body.

The Covid-19 pandemic had a positive impact on the Middle East nuclear imaging market as there is a rapid increase in the COVID-19 infected patients and these solutions are estimated to help in the smooth workflow during the treatment process and aids in decreasing contact with healthcare facilities, healthcare staff, and patients, in order to minimize the risk of COVID-19. Thereby, majority of the key players are involved in launching new products for the management of healthcare systems during the pandemic.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing awareness among clinical researchers and physicians regarding the benefits of nuclear imaging is expected to drive the market during the forecast period.
  • Rising applications of oncology, and neurological diseases are the foremost surging the demand for PET and SPECT.
  • Growing geriatric population and rising horizon of applications in PET and SPECT imaging due to significant developments and discovery of new radiopharmaceuticals are propelling the Nuclear imaging market.
  • Shortage of the radionuclide Tc99m (technetium 99), which is the primarily used isotope for imaging the body in nuclear medicine scans is anticipated to impede the market in coming years.
  • R&D investment and technological advancement in the Middle East nuclear imaging market are expected to offer lucrative opportunities for the market players.

Scope of the Report

The report on the Middle East nuclear imaging market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Middle East Nuclear Imaging Market -Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Product (Equipment and Radioisotope) and Application (PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) Applications)

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Bracco Imaging SpA, Cardinal Health Inc., GE Healthcare, Koninklijke Philips NV, and Siemens Healthineers

Market Segment insights

The radioisotope segment is projected to constitute a large market share

Based on product, the Middle East nuclear imaging market is segregated into equipment and radioisotope, the radioisotope is further divided into SPECT and PET. The radioisotope segment is expected to account for a key share of the market during the forecast period owing to its ability to provide high resolution images; it is primarily used in oncology as the images provided gives comprehensive information of the tumor. 

The SPECT segment is expected to register a substantial CAGR

Based on applications, the Middle East nuclear imaging market is divided into PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) Applications. The SPECT segment accounts for a key share of the market and is estimated to propel even further over the forecast period owing to the application of Technetium 99m in imaging, cardiac ventriculography, bone scans, brain imaging, and 3D scanning techniques; however, the PET segment is anticipated to expand at a rapid pace during the forecast period owing to the rising prevalence of various types of cancer and increasing demand for oncology for treatment of the same. Furthermore, PET is more sensitive than contrast-enhanced CT scan in the staging of various types of lymphoma or in detecting tumor dissemination in several solid cancers, such as lung cancer, breast cancer, and colon cancer.
 

Segments

Segments Covered in the Report
The Middle East nuclear imaging market has been segmented on the basis of:-
Product

  • Equipment
  • Radioisotope

Application

  • PET (Positron Emission Tomography)
  • SPECT (Single Photon Emission Computed Tomography)

Key Companies

  • Bracco Imaging SpA
  • Cardinal Health Inc.
  • GE Healthcare
  • Koninklijke Philips NV
  • Siemens Healthineers

 

Competitive Landscape

Key players competing in the Middle East nuclear imaging market includes Bracco Imaging SpA, Cardinal Health Inc., GE Healthcare, Koninklijke Philips NV, and Siemens Healthineers.
Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. For instance,

  • In May 2018, Curium intensified its position in the French PET market with the possession of Cyclopharma’s French manufacturing and commercial operations.

Middle East Nuclear Imaging Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nuclear Imaging Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Nuclear Imaging Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Nuclear Imaging Market - Supply Chain
  4.5. Global Nuclear Imaging Market Forecast
     4.5.1. Nuclear Imaging Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Nuclear Imaging Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Nuclear Imaging Market Absolute $ Opportunity
5. Global Nuclear Imaging Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Nuclear Imaging Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Nuclear Imaging Demand Share Forecast, 2019-2026
6. North America Nuclear Imaging Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Nuclear Imaging Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Nuclear Imaging Demand Share Forecast, 2019-2026
7. Latin America Nuclear Imaging Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Nuclear Imaging Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Nuclear Imaging Demand Share Forecast, 2019-2026
8. Europe Nuclear Imaging Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Nuclear Imaging Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Nuclear Imaging Demand Share Forecast, 2019-2026
9. Asia Pacific Nuclear Imaging Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Nuclear Imaging Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Nuclear Imaging Demand Share Forecast, 2019-2026
10. Middle East & Africa Nuclear Imaging Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Nuclear Imaging Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Nuclear Imaging Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Nuclear Imaging Market: Market Share Analysis
  11.2. Nuclear Imaging Distributors and Customers
  11.3. Nuclear Imaging Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Bracco Imaging SpA
     11.4.2. Cardinal Health Inc.
     11.4.3. GE Healthcare
     11.4.4. Koninklijke Philips NV
     11.4.5. Siemens Healthineers

Segments Covered in the Report
The Middle East nuclear imaging market has been segmented on the basis of:-
Product

  • Equipment
  • Radioisotope

Application

  • PET (Positron Emission Tomography)
  • SPECT (Single Photon Emission Computed Tomography)

Key Companies

  • Bracco Imaging SpA
  • Cardinal Health Inc.
  • GE Healthcare
  • Koninklijke Philips NV
  • Siemens Healthineers

 

Key players competing in the Middle East nuclear imaging market includes Bracco Imaging SpA, Cardinal Health Inc., GE Healthcare, Koninklijke Philips NV, and Siemens Healthineers.
Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. For instance,

  • In May 2018, Curium intensified its position in the French PET market with the possession of Cyclopharma’s French manufacturing and commercial operations.

Middle East Nuclear Imaging Market keyplayers

Buy Report